We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLOB:NYSEGlobant S.A. Analysis

Data as of 2026-08-16 - not real-time

$37.38

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Globant S.A. is priced at $37.38, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 19.1%. Relative strength is 54.9 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $29.26 and resistance around $41.65.
On valuation the read is undervalued — earnings multiple of 14.6 versus a 36.5 sector average, below the peer group. Sell-side targets cluster 37.3% above the current quote.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 66.7%, a beta of 0.88 and a maximum drawdown of 61.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

GLOB Deadline Alert: Levi & Korsinsky Reminds Globant S.GLOB FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Globant S.Benzinga.com2dGlobant Analysts Cut Their Forecasts After Q2 ResultsGlobant SA NYSE: GLOB reported mixed second-quarter...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 49.34
  • MACD momentum is positive
  • 30-day price change of +19.1%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 14.6 versus sector average of 36.5
  • Trading below the 200-day average of 49.34
  • Analyst targets imply +37.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 14.6 versus sector average of 36.5
  • Analyst targets imply +37.3% versus the current price
  • 30-day volatility of 66.7%

Key Metrics & Analysis

Financial Health

Profit Margin4.63%
P/E Ratio14.6
ROE5.48%
ROA4.67%
Debt/Equity23.82
P/B Ratio0.8
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI54.9
Support$29.26
Resistance$41.65
MA 20$35.60
MA 50$34.10
MA 200$49.34
MACDBullish
VolumeIncreasing
Fear & Greed Index95.98

Valuation

Target Price$51.32
Upside/Downside37.29%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.88
Volatility66.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.